ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 17 filers reported holding ARCA BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $35,000 | +12.9% | 93,258 | 0.0% | 0.02% | +6.7% |
| Q4 2018 | $31,000 | -46.6% | 93,258 | 0.0% | 0.02% | -42.3% |
| Q3 2018 | $58,000 | +11.5% | 93,258 | 0.0% | 0.03% | +13.0% |
| Q2 2018 | $52,000 | +10.6% | 93,258 | 0.0% | 0.02% | +15.0% |
| Q1 2018 | $47,000 | -62.7% | 93,258 | 0.0% | 0.02% | -52.4% |
| Q4 2017 | $126,000 | +17.8% | 93,258 | -0.0% | 0.04% | +13.5% |
| Q3 2017 | $107,000 | -52.4% | 93,268 | -0.4% | 0.04% | -53.2% |
| Q2 2017 | $225,000 | +82.9% | 93,667 | +93.7% | 0.08% | +75.6% |
| Q1 2017 | $123,000 | -81.4% | 48,345 | -79.1% | 0.04% | -76.1% |
| Q4 2016 | $661,000 | – | 231,775 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 562,693 | $1,632,000 | 0.23% |
| NEA Management Company, LLC | 1,460,209 | $4,235,000 | 0.22% |
| Tekla Capital Management LLC | 811,227 | $2,353,000 | 0.10% |
| ROYCE & ASSOCIATES LP | 152,733 | $443,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,216,840 | $3,529,000 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,452 | $30,000 | 0.00% |
| Camarda Financial Advisors, LLC | 200 | $1,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 77,408 | $224,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 142 | $0 | 0.00% |
| BlackRock Investment Management, LLC | 1,046 | $3,000 | 0.00% |